Review
Open access
Aug 2026
Efficacy and safety of first-line immune checkpoint inhibitors combinations for extensive-stage small-cell lung cancer: A systematic review and network meta-analysis
First-line ICI-chemotherapy combinations improved survival outcomes but increased the risk of irAEs, with no significant differences in efficacy or safety among ICI-chemotherapy combinations.
Xiao-Qi Ye, Haoru Meng, Qiuyan Guo et al.
· Medicine · 0 citations